<DOC>
	<DOCNO>NCT01958034</DOCNO>
	<brief_summary>In double blind , randomize , clinical trial patient suffer STEMI ( ST-segment elevation myocardial infarction ) non-STEMI ( non-ST-segment elevation myocardial infarction ) compare effect 3 month dietary supplement bilberry extract range parameter prognostic importance cardiovascular disease : lipid , inflammation , oxidative stress heart function . Following inclusion 8 individual February 12 , 2014 : Due intolerance `` bilberry placebo powder '' amend protocoll trial design change blind open bilberry arm trial carry open design control group receive dietary supplement .</brief_summary>
	<brief_title>Bilberry Dietary Supplement After Myocardial Infarction ( The BEAR SMART Trial )</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Patients diagnosis STEMI define chest pain suggestive myocardial ischemia least 30 minute hospital admission , time onset symptom less 24 hour , ECG new STsegment elevation two contiguous lead ≥0.2 mV lead V2V3 and/or ≥0.1 mV lead probable newonset leave bundle branch block . Patients diagnosis nonSTEMI defined combination ; onset symptoms central chest pain aggravate angina pectoris , without ECG change STsegment lowering invert Twave , least two value level troponinT troponinI establish margin MI . Need emergency coronary artery bypass graft Inability provide inform consent Age 18 year Previous randomization BEAR SMART trial A daily intake , intent start daily intake bilberry form ( fresh berry , bilberry powder , bilberrysoup etc ) Need emergency coronary artery bypass graft Inability provide inform consent Age 18 year Previous randomization BEAR SMART trial A daily intake , intent start daily intake bilberry form ( fresh berry , bilberry powder , bilberrysoup etc )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>